If Morality Challenges Profit, Profit Seldom Loses

In June (2002), the New England Journal of Medicine, one of the most respected medical journals, made a startling announcement. The editors declared that they were dropping their policy stipulating that authors of review articles of medical studies could not have financial ties to drug companies whose medicines were being analyzed.

The reason? The journal could no longer find enough independent experts.

Drug company gifts and "consulting fees" are so pervasive that in any given field, you cannot find an expert who has not been paid off in some way by the industry. So the journal settled for a new standard: Their reviewers can have received no more than $10,000 (per year) from "companies whose work they judge."

Isn't that comforting?

This announcement by the New England Journal of Medicine is just the tip of the iceberg of a scientific establishment that has been pervasively corrupted by conflicts of interest and bias, throwing doubt on almost all scientific claims made in the biomedical field.

The standard announced in June was only for the reviewers. The actual authors of scientific studies in medical journals are often bought and paid for by private drug companies, with a stake in the scientific results.

While the NEJM and some other journals disclose these conflicts, others do not. Unknown to many readers is the fact that the data being discussed was often collected and analyzed by the maker of the drug involved in the test.

In other words, there are many alternative treatments for cancer that will not provide Big Pharma a single penny of revenue, much less profits. This means these same treatments will not provide the media with a single penny of revenue either.

Guess which treatments the media pushes? In fact, the Federal Trade Commission won't allow alternative cancer treatments to be advertised, because all of them are "unproven" (translation: not profitable to Big Pharma). There are ways to get around this FTC rule, such as a book author creating an infomercial promoting his book.

There is a war going on in medicine today; a war between orthodox (allopathic) medicine and alternative (natural) medicine. The war is being fought with money and information. The war is to control what you know, and don't know, about cancer treatments.

The war is to control whether you know the truth about all of your cancer treatment options.

When a new discovery is made, the only question that is asked is this: "Is it profitable enough?" If the answer is 'no' the treatment is buried.

Now, perhaps you know why medical costs continue to skyrocket through the roof. When a new natural nutrient is found that is proven to kill cancer cells or stop the spread of cancer, do they ask whether this nutrient can be used in a natural treatment for cancer? Of course not!

The first question that is asked is this:

"How can we mutate and synthesize this nutrient, patent it, and make it into a profitable drug?" And with the media we can bury the natural alternative.

Ponder that last paragraph carefully, because it is the heart and soul of modern medicine. Find a natural substance that cures something, bury this fact, then fabricate, synthesize, and mutate the key natural substance, then patent the mutation, and make huge profits.

That is why there is "no scientific evidence" for alternative treatments; no one is looking, because they cannot be patented and thus are not profitable enough.

Do you want to know the mark-up of some common drugs?
The U.S. Commerce Department did, and came up with
some interesting numbers

Product Name - tab size - quantity - $ retail - $ Mfg Cost - Profit %

Celebrex 100 mg - (100 tablets): $130.27 - $0.60 - 21,712%
Claritin 10 mg - (100 tablets): $215.17 - $0.71 - 30,306%
Norvasc 10 mg - (100 tablets): $188.29 - $0.14 - 134,493%
Prevacid 30 mg - (100 tablets): $44.77 - $1.01 - 34,136%
Prilosec 20 mg - (100 tablets): $360.97 - $0.52 - 69,417%
Prozac 20 mg - (100 tablets) : $247.47 - $0.11 - 224,973%
Tenormin 50 mg - (100 tablets): $104.47 - $0.13 - 80,362%
Vasotec 10 mg - (100 tablets): $102.37 - $0.20 - 51,185%
Xanax 1 mg - (100 tablets) : $136.79 - $0.024 - 569,958%

Big Pharma claims that these prices are necessary for them to continue with their extensive and expensive research, plus the lobby efforts to get a speedy approval.

Can you believe the gall and audacity of the Big Pharma companies! Most of their mark-up is designed to cover other costs, such as lobbyists and advertising. Do you see what is going on here? The reason there is no official "scientific evidence" for alternative cancer treatments and cancer prevention treatments is that they are not highly profitable when compared to Big Pharma. It is impossible, by law, for a substance to be considered to have scientific evidence unless Big Pharma submits it to the FDA (and they subsequently approve it), and they will only submit things that are very, very profitable to them. That's just how business operates, consumers are not considered important.

It is the Big Plan of Big Pharma to destroy alternative medicine, especially as it relates to their most profitable products, such as cancer drugs, heart drugs, allergy drugs, etc.

Seed Newsvine

Bookmark this article in your preferred program

Comments

Add Comment

Popular Articles in this cathegory

This article is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.